IB
Illuminare Biotechnologies Inc
SEC filingBiotechnology · Brooklyn, NY
Amount raised$3.7Msold at filing
Total offering$4M$350K still open
Investors in the raise42count reported to the SEC
FiledJun 4, 2026first sale May 7, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ezra AngristPromoter
Oliver CurmeDirector
Walter GreenblattExecutive Officer, Director, Promoter
Eric EdidinDirector
Andrew FradkinPromoter
Brian LongstreetExecutive Officer, Director
Shay GrinfeldDirector, Promoter
Robert GraifmanDirector, Promoter
Executive officers, directors and promoters as listed on the Form D.